Delivery Order SPE2DB22D3011-SPE2DB25FQ0PG

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a specialty medication, and has a total ceiling value of $10,017.28. The contract has an ultimate completion date of March 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 10 mg/0.5 ml pens. The contract has a ceiling value of $1,557.65 and a period of performance through October 12, 2023. It is a firm-fixed-price contract, indicating pre-determined pricing. The contract does not have a set-aside designation, suggesting open competition. AmerisourceBergen holds a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,088.36, is for the supply of Mounjaro 12.5 mg/0.5 ml pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at $999,999,999.00. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,347.06, is for the supply of Mounjaro 5 mg/0.5 ml pens and has a period of performance through March 31, 2025. The contract is a firm fixed-price type with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 10 mg/0.5 ml pens. The contract has a firm fixed price of $1,486.06 and a performance period running through January 15, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mounjaro 10 mg/0.5 ml pens, a diabetes medication. The contract has a ceiling value of $3,011.39 and a performance period ending on April 29, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,478.54 fixed-price contract is for the delivery of Mounjaro, a 5 mg/0.5 ml medication pen, with a completion date of May 12, 2023. The contract is not associated with any set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,710.16, is for the supply of the medication Mounjaro 10 mg/0.5 mL pen, a 0.5 mL product. The delivery order has a firm fixed price and an ultimate completion date of December 3, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $5,786 contract is for the delivery of Mounjaro 10 mg/0.5 ml pens to support military treatment programs and medical facilities. The delivery order falls under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,265.08, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price contract. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FQ0PG
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,883.60, is for the supply of Mounjaro 10 mg/0.5 ml pens. This is a firm fixed-price contract with an ultimate completion date of April 29, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract supports the broader medical procurement needs of various government agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/28/25, 11:01 AM